Anti-tumor necrosis factor (anti-TNF) therapy has been successfully used for more than 20 years to treat inflammatory bowel diseases (IBDs), such as Crohn’s disease (CD) and ulcerative colitis (UC) [1]. The gene discussed is TNF; the disease is inflammatory bowel disease.